Non-human primate models of multiple sclerosis

被引:59
作者
Brok, HPM
Bauer, J
Jonker, M
Blezer, E
Amor, S
Bontrop, RE
Laman, JD
't Hart, BA
机构
[1] Biomed Primate Res Ctr, Dept Immunobiol, NL-2288 GJ Rijswijk, Netherlands
[2] Univ Vienna, Brain Res Inst, Vienna, Austria
[3] Univ Utrecht, Imaging Sci Inst, NL-3508 TC Utrecht, Netherlands
[4] Leiden Univ, Med Ctr, Blood Bank, Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Immunohaematol, Leiden, Netherlands
[6] Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands
[7] Univ Utrecht, Dept Pharmacol & Pathophysiol, Utrecht, Netherlands
关键词
D O I
10.1034/j.1600-065x.2001.1830114.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The phylogenetic proximity between non-human primate species and humans is reflected by a high degree of immunological similarity. Non-human primates therefore provide important experimental models for disorders in the human population that are caused by the immune system, such as autoimmune diseases. In this paper we describe non-human primate models of multiple sclerosis, a chronic inflammatory and demyelinating disease of the human central nervous system. While reviewing data from the literature and our own research we will discuss the unique role of such models in the research of basic disease mechanisms and the development of new therapies.
引用
收藏
页码:173 / 185
页数:13
相关论文
共 84 条
  • [1] ABO S, 1993, BIOCHEM MOL BIOL INT, V30, P945
  • [2] MYELIN BASIC-PROTEIN TREATMENT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN MONKEYS
    ALVORD, EC
    SHAW, CM
    HRUBY, S
    [J]. ANNALS OF NEUROLOGY, 1979, 6 (06) : 469 - 473
  • [3] ALVORD EC, 1984, EXPT ALLERGIC ENCEPH, V146, P523
  • [4] The common marmoset:: A new world primate species with limited Mhc class II variability
    Antunes, SG
    de Groot, NG
    Brok, H
    Doxiadis, G
    Menezes, AAL
    Otting, N
    Bontrop, RE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) : 11745 - 11750
  • [5] SAFETY AND EFFICACY OF THERAPEUTIC MONOCLONAL-ANTIBODIES IN CLINICAL-THERAPY
    BACH, JF
    FRACCHIA, GN
    CHATENOUD, L
    [J]. IMMUNOLOGY TODAY, 1993, 14 (09): : 421 - 425
  • [6] CONTROL OF ESTABLISHED EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY INHIBITION OF TUMOR-NECROSIS-FACTOR (TNF) ACTIVITY WITHIN THE CENTRAL-NERVOUS-SYSTEM USING MONOCLONAL-ANTIBODIES AND TNF RECEPTOR IMMUNOGLOBULIN FUSION PROTEINS
    BAKER, D
    BUTLER, D
    SCALLON, BJ
    ONEILL, JK
    TURK, JL
    FELDMANN, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) : 2040 - 2048
  • [7] Apoptosis in brain-specific autoimmune disease
    Bauer, J
    Wekerle, H
    Lassmann, H
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (06) : 839 - 843
  • [8] Major histocompatibility complex class II polymorphisms in primates
    Bontrop, RE
    Otting, N
    de Groot, NG
    Doxiadis, GGM
    [J]. IMMUNOLOGICAL REVIEWS, 1999, 167 : 339 - 350
  • [9] EVOLUTION OF MAJOR HISTOCOMPATIBILITY COMPLEX POLYMORPHISMS AND T-CELL RECEPTOR DIVERSITY IN PRIMATES
    BONTROP, RE
    OTTING, N
    SLIERENDREGT, BL
    LANCHBURY, JS
    [J]. IMMUNOLOGICAL REVIEWS, 1995, 143 : 33 - 62
  • [10] Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses
    Boon, L
    Brok, HPM
    Bauer, J
    Ortiz-Buijsse, A
    Schellekens, MM
    Ramdien-Murli, S
    Blezer, E
    van Meurs, M
    Ceuppens, J
    de Boer, M
    't Hart, BA
    Laman, JD
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (05) : 2942 - 2949